US Stock MarketDetailed Quotes
VIR Vir Biotechnology
- 12.480
- +4.590+58.17%
Close Jan 8 16:00 ET
- 12.750
- +0.270+2.16%
Post 20:01 ET
1.72BMarket Cap-3.18P/E (TTM)
14.450High11.470Low39.49MVolume12.550Open7.890Pre Close502.03MTurnover42.58%Turnover RatioLossP/E (Static)137.72MShares14.45052wk High1.39P/B1.16BFloat Cap6.56052wk Low--Dividend TTM92.74MShs Float141.010Historical High--Div YieldTTM37.77%Amplitude6.560Historical Low12.713Avg Price1Lot Size
Vir Biotechnology Stock Forum
Sign in to post a comment
2
3
$Vir Biotechnology (VIR.US)$ bought in too high.. have to hold it.. potential stock for future.
1
1
$Vir Biotechnology (VIR.US)$
Congratulations to trader who have bought it on premarket for day trade profit.
Market is going downtrend for the incoming fed announcement. Lock on profit today as tomorrow market will be closed.
Today good opportunity to swing trade $ $Sana Biotechnology (SANA.US)$ $Absci Corp (ABSI.US)$
Pick the right momentum stock to trade for profit.
Follow me, follow momentum
Congratulations to trader who have bought it on premarket for day trade profit.
Market is going downtrend for the incoming fed announcement. Lock on profit today as tomorrow market will be closed.
Today good opportunity to swing trade $ $Sana Biotechnology (SANA.US)$ $Absci Corp (ABSI.US)$
Pick the right momentum stock to trade for profit.
Follow me, follow momentum
$Palantir (PLTR.US)$ nice cash grab. keep on holdin guys lol. $Vir Biotechnology (VIR.US)$ to the moon see u at 20
5
2
1
$Vir Biotechnology (VIR.US)$ Benzinga· 1 min ago
Vir Biotechnology Is Presenting Initial Phase 1 Data From Two Of Its Dual-masked T-cell Engagers (TCEs): VIR-5818, Targeting A Variety Of HER2-expressing Solid Tumors; And VIR-5500, Targeting PSMA In Metastatic Castration-resistant Prostate Cancer
Vir Biotechnology Inc - Vir-5818 Shows 50% Tumor Shrinkage in Her2 Cancers at ≥400 ΜG/Kg
Vir Biotechnology Is Presenting Initial Phase 1 Data From Two Of Its Dual-masked T-cell Engagers (TCEs): VIR-5818, Targeting A Variety Of HER2-expressing Solid Tumors; And VIR-5500, Targeting PSMA In Metastatic Castration-resistant Prostate Cancer
Vir Biotechnology Inc - Vir-5818 Shows 50% Tumor Shrinkage in Her2 Cancers at ≥400 ΜG/Kg
2
$Vir Biotechnology (VIR.US)$ $Eli Lilly and Co (LLY.US)$ Reuters· 2 mins ago
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
DDDDDDDDDDD : $Color Star Technology (ADD.US)$ and $Snow Lake Resources (LITM.US)$ lets go
Trytosaveabit OP DDDDDDDDDDD : Indeed! SS’s are Makin on those 2 today along with about 75% of the rest of the market! Hehehe
Jenna Ragan : wow!